NantHealth and Allscripts Join Forces to Develop Precision Solutions at Point of Care in This Era of Genomic Medicine

AllscriptsNantHealth and Allscripts (Nasdaq:MDRX) will collaborate on the development and delivery of cutting-edge, precision medicine solutions directly to the point of care. The companies will introduce an integrated, evidence-based, personalized approach to healthcare solutions that includes actionable clinical data, enabling physicians to make informed decisions from complex genomic and proteomic analysis.

"Our goal is to enable physicians to make better, more informed decisions, provide best-in-class patient care and monitor the effectiveness and progress of treatment, using real-time clinical and pan-omic data never before available," said Dr. Patrick Soon-Shiong, founder and chief executive officer of NantHealth. "We look forward to working in partnership with the Allscripts team as the first major Clinical EMR vendor to take a major advancement towards the interoperability necessary to enable physicians and patients to stay engaged and active - before, during and after treatment - and enable the most appropriate, personalized intervention as early as possible."

Transforming Cancer Care
Research has shown that a physician's ability to make effective, evidence-based clinical decisions can improve by using specifically matched cancer protocols and drugs, delivered to the patient based on the individual's unique DNA, RNA and proteomic profile, and integrated with the patient's holistic clinical picture. For the first time, NantHealth and Allscripts can integrate these two aspects into a unique knowledge-based solution to significantly improve the way clinicians treat cancer.

Beginning with genomic (DNA) and transcriptome (RNA) sequencing, foundational data on how a patient is likely to respond to a specific treatment protocol will integrate with big data and data-mining-based computational analysis. These new NantHealth technologies will enable providers to determine the most accurate treatment option in today's complex world of genomically driven cancer care.

With this comprehensive view of the patient from all data sources, physicians can then use NantHealth's eviti solution, a comprehensive oncology decision support application that helps select the optimal protocol for patients and verifies their eligibility for it. The eviti platform empowers oncologists with real-time, actionable, evidence-based treatment and clinical trial information to help them make informed treatment decisions for their patients.

Managing Population Health
NantHealth can gather and monitor patient data via NantHealth's DeviceConX and Hbox, an industry leading medical device data integration solution that works at the point of care for clinicians or at home for the patient. Combined with critical clinical data from the physician's EMR and community data collected across the continuum of care, clinicians can proactively manage and monitor populations of patients over time and optimize their treatment. Clinicians can then identify all relevant outcomes, improvements and gaps in care, and make them available within the care providers' workflow regardless of their environment.

Together, physicians and patients will have the tools to stay engaged and active and provide necessary intervention as early as possible. Leveraging innovations in patient engagement, care coordination and disease management, NantHealth and Allscripts are creating the first fully comprehensive and integrated platform that will provide a transformation to the coordination and delivery of cancer care.

"We're working with NantHealth to create a game-changing platform for coordinated cancer care," Allscripts Chief Executive Officer Paul M. Black said. "Integrated patient information - from the molecular level and from the entire continuum of care - is a powerful tool to improve health care."

About Allscripts
Allscripts (Nasdaq:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of HealthTM. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

About NantHealth
NantHealth, a member of the NantWorks ecosystem of companies, is a transformational healthcare IT company converging science and technology through a single integrated clinical platform, to provide actionable health information at the point of care, in the time of need, anywhere, anytime. NantHealth works to transform clinical delivery with actionable clinical intelligence at the moment of decision, enabling clinical discovery through real-time machine learning systems. The company's technology empowers physicians, patients, payers and researchers to transcend genomics into the world of proteomics and the traditional barriers of today's healthcare system. By converging molecular science, computer science and big data technology the NantHealth Clinical Operating System (cOS) platform empowers physicians, patients, and payers to coordinate best care, monitor outcomes and control cost in real time. This is the first operating system of its kind in healthcare that is based on supply chain principles and grid service oriented architecture and integrates the knowledge base with the delivery system and the payment system, enabling 21st century coordinated care at a lower cost.

Most Popular Now

Hull University Teaching Hospitals NHS T…

Hull University Teaching Hospitals NHS Trust has deployed DXC Technology's (NYSE:DXC) cloud-based Clinical Aide mobile application, which both improves secure access to electronic patient medical records and increases patient and...

Central Hospital in Finland Automates Sy…

This November Central Ostrobothnia Central Hospital in Finland has started symptom tracking and remote monitoring of corona virus-infected patients with the Buddy Healthcare mobile application and clinical monitoring platform. The...

Healthcare App Reduces Symptoms of COPD …

COPD is a common respiratory condition and one of the top causes of hospital admissions each year, particularly during winter months. In the UK it accounts for over 140,000 hospital...

Ultrapotent COVID-19 Vaccine Candidate D…

An innovative nanoparticle vaccine candidate for the pandemic coronavirus produces virus-neutralizing antibodies in mice at levels ten-times greater than is seen in people who have recovered from COVID-19 infections. Designed...

Interactive virtual reality emerges as a…

Bristol scientists have demonstrated a new virtual reality [VR] technique which should help in developing drugs against the SARS-CoV-2 virus - and enable researchers to share models and collaborate in...

Softphone App to Save NHS up to £20 Mill…

GPs and patients are to benefit from a new softphone app that will eliminate almost all the "hidden cost" of calls for remote consultations and is forecast to save the...

More than 1,000 Exhibitors have Already …

16 - 19 November 2020, Düsseldorf, Germany. This year, the world's largest and leading medical trade fair, MEDICA, and the number one international event for the medical technology manufacturing supplier market...

App to Help NHS Prevent Deadly Hospital …

Compass app to help NHS trusts prevent hospital-acquired acute kidney injury and pneumonia - both of which cause harm to COVID-19 patients and can be fatal. Hospitals could alleviate pressure...

DMEA Newcomer Award: The Search is on fo…

13 - 15 April 2021, Berlin, Germany. More efficient, digital and patient-friendly! Tomorrow's healthcare system promises great things. And to ensure this becomes reality a fresh impetus and creative ideas are...

Leeds Deploys Imaging Tech for Advanced …

A multi-million pound initiative that is digitising, connecting and applying artificial intelligence to NHS pathology services in the North of England has taken an important step, after Leeds Teaching Hospitals...

Survey of COVID-19 Research Provides Fre…

Researchers at Karolinska Institutet in Sweden have explored all COVID-19 research published during the initial phase of the pandemic. The results, which were achieved by using a machine learning-based approach...